Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An update from PuraPharm Corp. Ltd. ( (HK:1498) ) is now available.
PuraPharm Corporation Limited has announced the composition of its board of directors, highlighting the roles and functions of each member. This announcement provides clarity on the leadership structure, which is crucial for stakeholders to understand the governance and strategic direction of the company.
The most recent analyst rating on (HK:1498) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on PuraPharm Corp. Ltd. stock, see the HK:1498 Stock Forecast page.
More about PuraPharm Corp. Ltd.
PuraPharm Corporation Limited is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. It focuses on the development and distribution of traditional Chinese medicine products.
Average Trading Volume: 221,525
Technical Sentiment Signal: Sell
Current Market Cap: HK$177.7M
For a thorough assessment of 1498 stock, go to TipRanks’ Stock Analysis page.